Department of Chemistry & Biochemistry
ANNOUNCEMENTS
Interested in
Graduate Studies in
Chem & Biochem?
Click here for more information!
MORE DEPARTMENTAL HIGHLIGHTS
Pappas Receives Chancellor's Council Research Award
Photos
Chemistry Celebrates Opening of Renovated Room
Scott Hiemstra selected to receive a 2011 Distinguished Staff Award from the Office of the President
Dr. Hase Featured in the 2011 Arts & Sciences Magazine
Bartsch Named ACS Fellow for Work with Chemical Ligands
Our Research Professors:
Adélia Aquino
Hans Lischka
Our Joint Faculty:
Juske Horita
Moria Ridley
Brandon Weeks
From here, it's possible.
Our Newest Faculty Members: | |
Dr. Michael Findlater | Dr. Yehia Mechref |
| Professor Findlater has joined the department from the University of North Carolina, where he was a postdoctoral scientist. His research focuses on catalysis involving small molecules and the study of C-H bond activation. | Professor Mechref was recruited to Texas Tech University from Indiana University where he was Director of the METACyt Biochemical Analysis Center and Assistant Director of the National Center for Glycomics and Glycoprotemics. |
Dr. Nes publishes Chemical Reviews article | Dr. Morales receives grant to predict ESR tensors for petroleum species |
| Professor Nes and his co-workers are investigating the biosynthesis of cholesterol and other sterols. Their work is featured in the Chemical Reviews issue on Lipid Biochemistry, Metabolism and Signaling. | With a grant from the ACS-Petroleum Research Fund, Professor Morales is developing computational methods to accurately predict electronic spin resonance tensors and their applications to the observed ESR spectra of petroleum species. |
Dr. Li Receives National Institutes of Health Grant | Dr. Knaff Receives Department of Energy Grant |
| Professor Li is developing new synthetic methods to aid the discovery of pharmaceutical compounds and their building blocks. | Professor Knaff and his co-workers are investigating plant enzymatic mechanisms involving the protein ferredoxin. |
New Method Could Lead to Better Treatments for Cancer & Heart Disease | Dr. Shaw awarded new patent |
| Professor Pappas is studying cell death with a $520,000 NIH grant that could lead to more useful medications for ailments such as heart disease and cancer. | Professor Shaw and co-worker K.M. Kim have been awarded a patent for the development of an RNA inhibitor of metallo-ß-lactamase. It is the third patent in a series issued to Professor Shaw dealing with technology that is aimed at reducing the serious medical and pharmaceutical problem of antibiotic resistance in pathogenic bacteria. |



